How does brain insulin resistance develop in Alzheimer's disease?

Slides:



Advertisements
Similar presentations
TNF-α Mediates PKR-Dependent Memory Impairment and Brain IRS-1 Inhibition Induced by Alzheimer’s β-Amyloid Oligomers in Mice and Monkeys Mychael V. Lourenco,
Advertisements

Signaling and the Signal Transduction Cascade. Question?????? External Stimulus Inside cell Nucleus, Gene transcription Other cellular effects.
2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.
Cell Communication. Communication Cells must communicate with other cells and respond to their environment Basic communication processes are shared across.
Long Term Potentiation
The nature, significance, and glucagon-like peptide-1 analog treatment of brain insulin resistance in Alzheimer's disease  Konrad Talbot, Hoau-Yan Wang 
Lipotoxicity in NASH Journal of Hepatology
High-mobility group box-1 protein induces osteogenic phenotype changes in aortic valve interstitial cells  Bo Wang, PhD, Fei Li, MD, Chao Zhang, PhD,
Novel insights in the interplay between inflammation and metabolic diseases: A role for the pathogen sensing kinase PKR  Nicolas Marsollier, Pascal Ferré,
Ischemic cardiovascular involvement in psoriasis: A systematic review
All roads lead to FoxO Cell Metabolism
Acetylation Unleashes Protein Demons of Dementia
Volume 142, Issue 6, Pages (May 2012)
Lipotoxicity in NASH Journal of Hepatology
Biologic therapy of inflammatory bowel disease
B-cell Signaling: Protein Kinase Cδ Puts the Brakes on
Toll-like receptors in Borrelia burgdorferi-induced inflammation
Kinase inhibitors: Vice becomes virtue
Signaling molecules as therapeutic targets in allergic diseases
From mesothelioma to cardiovascular protection via the phosphoinositide-3 kinase pathway: A new vista in cardiothoracic surgery  Igor E. Konstantinov,
Safia Costes, Peter C. Butler  Cell Metabolism 
Figure 2 Oestrogen receptor signalling pathways
Endoplasmic reticulum stress in liver disease
Ischemic cardiovascular involvement in psoriasis: A systematic review
BDNF and insulin signaling pathways activated by phytochemicals.
Severe asthma: Advances in current management and future therapy
TNF-α–induced protein 3 (A20): The immunological rheostat
Development of PI3K/AKT/mTOR Pathway Inhibitors and Their Application in Personalized Therapy for Non–Small-Cell Lung Cancer  Vassiliki Papadimitrakopoulou,
Vascular dysfunction in diabetes mellitus
Tumor Necrosis Factor Cell
A Liver Full of JNK: Signaling in Regulation of Cell Function and Disease Pathogenesis, and Clinical Approaches  Ekihiro Seki, David A. Brenner, Michael.
The incretin hormones glucagonlike peptide 1 and glucose-dependent insulinotropic polypeptide are neuroprotective in mouse models of Alzheimer's disease 
Inhibition of mammalian target of rapamycin: Two goals with one shot?
Targeting Transcription to the Neuromuscular Synapse
The paradox of neuronal insulin action and resistance in the development of aging- associated diseases  Sophie M. Steculorum, Maite Solas, Jens C. Brüning 
Peter J. Barnes, FRS, FMedSci 
Volume 18, Issue 6, Pages (December 2013)
Selective Insulin and Leptin Resistance in Metabolic Disorders
Non-canonical Signaling, the Hidden Life of Ligand-Gated Ion Channels
Modulation of inflammation by chondroitin sulfate
Volume 140, Issue 6, Pages (March 2010)
Estrogen Receptors and the Metabolic Network
Roles of fibrinolytic system components in the nervous system
Elucidating the Role of TREM2 in Alzheimer’s Disease
Herbert Tilg, Gökhan S. Hotamisligil  Gastroenterology 
Claire Z. Larter, Geoffrey C. Farrell  Journal of Hepatology 
Nanna Fyhrquist, Sampsa Matikainen, Antti Lauerma 
Death receptor-mediated apoptosis and the liver
RAS and PD-L1: A Masters’ Liaison in Cancer Immune Evasion
Epigenetic Mechanisms in Cognition
A Ceramide-Centric View of Insulin Resistance
Banking on ATM as a new target in metabolic syndrome
p38δ and PKD1: Kinase Switches for Insulin Secretion
Signalling links in the liver: Knitting SOCS with fat and inflammation
Insulin Resistance in the Defense against Obesity
Fyn-Tau-Amyloid: A Toxic Triad
Astrocytes: Powering Memory
SCOPing out Proteases in Long-Term Memory
Can Eph Receptors Stimulate the Mind?
The nature, significance, and glucagon-like peptide-1 analog treatment of brain insulin resistance in Alzheimer's disease  Konrad Talbot, Hoau-Yan Wang 
Volume 104, Issue 4, Pages (February 2001)
Vanessa L. Ott, PhD, John C. Cambier, PhD 
Tumor necrosis factor-α in cisplatin nephrotoxicity: A homebred foe?
Macrophages, Immunity, and Metabolic Disease
SCOPing out Proteases in Long-Term Memory
Apoptosis: Activate NF-κB or die?
Airway smooth muscle: An immunomodulatory cell
Dendritic Tau in Alzheimer’s Disease
Tackling Resistance to PI3K Inhibition by Targeting the Epigenome
Christian Rask-Madsen, George L. King  Cell Metabolism 
Presentation transcript:

How does brain insulin resistance develop in Alzheimer's disease? Fernanda G. De Felice, Mychael V. Lourenco, Sergio T. Ferreira  Alzheimer's & Dementia: The Journal of the Alzheimer's Association  Volume 10, Issue 1, Pages S26-S32 (February 2014) DOI: 10.1016/j.jalz.2013.12.004 Copyright © 2014 The Alzheimer's Association Terms and Conditions

Fig. 1 Impaired neuronal insulin signaling in Alzheimer's disease (AD). Schematic outline of neuronal insulin signaling in normal brain (left) and AD brain (right). Under physiological conditions, insulin binding to its cell surface receptor (insulin receptor [IR]) triggers IR autophosphorylation and subsequent tyrosine phosphorylation of insulin receptor substrate 1 (IRS-1). This results in phosphoinositide 3-kinase (PI3K) activation and downstream cellular responses that facilitate synaptic plasticity and memory. Activity-dependent calcium (Ca2+) influx via N-methyl-D-aspartate receptors (NMDARs) activates signaling and expression of genes involved in synaptic plasticity and memory. A crosstalk between NMDAR- and IR-dependent signaling may modulate the actions of insulin on memory. In AD, accumulation of amyloid-β (Aβ) oligomers leads to increased tumor necrosis factor-α (TNF-α) levels and activation of stress kinases (c-Jun N-terminal kinase [JNK], double-stranded ribonucleic acid [RNA]-dependent protein kinase [PKR], and IκBα kinase [IKK]), resulting in inhibitory serine phosphorylation of IRS-1. Aβ oligomers instigate additional removal of IRs from the cell surface and redistribution to the cell body. These combined events block neuronal insulin signaling. Aberrant activation of NMDARs by Aβ oligomers results in excessive Ca2+ influx, neuronal oxidative stress, and disrupted signaling, leading to impaired synaptic plasticity. Under these conditions, putative activation of protein tyrosine phosphatases may inhibit IRS-1 signaling further, ultimately leading to synapse impairment and memory failure. pSer, phosphoserine; pTyr, phosphotyrosine; TNFR, TNFa receptor. Alzheimer's & Dementia: The Journal of the Alzheimer's Association 2014 10, S26-S32DOI: (10.1016/j.jalz.2013.12.004) Copyright © 2014 The Alzheimer's Association Terms and Conditions